Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/28/2025

Differential Diagnosis and Management of Extragonadal Germ Cell Tumors

Critical Immunohistochemical Interpretation

  • The National Comprehensive Cancer Network recommends that LCA (CD45) positivity, which initially suggests lymphoma, can be seen in certain germ cell tumor components and does not exclude this diagnosis, with a staining pattern providing crucial diagnostic information 1, 2
  • The National Comprehensive Cancer Network suggests that Pan-cytokeratin negativity argues against carcinoma but does not exclude germ cell tumors, particularly those with primitive or undifferentiated components 1, 2

Immediate Diagnostic Workup Required

  • The American College of Radiology and other societies imply that if dysgerminoma is suspected in the differential, particularly in younger patients, karyotype consideration may be necessary 3

If Lymphoma Cannot Be Excluded

  • The National Comprehensive Cancer Network recommends that core needle biopsy may be insufficient if lymphoma remains in the differential after initial pathology review, and consideration of repeat biopsy with flow cytometry and additional immunohistochemical staining is necessary 1, 2
  • The National Comprehensive Cancer Network advises to avoid inappropriate resection, with the goal of preventing major surgical resection of a chemotherapy-sensitive tumor like lymphoma 1, 2

Referral to Specialized Center

  • The National Comprehensive Cancer Network suggests that this patient must be managed at a center with extensive expertise in germ cell tumors, as adherence to evidence-based guidelines is associated with improved survival outcomes in rare and complex sarcomas and germ cell tumors 1, 2